Skip to main content
CHRS
NASDAQ Life Sciences

Coherus Declares CVR Dividend, Launches Sale of Legacy Biosimilars

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.23
Mkt Cap
$177.676M
52W Low
$1.02
52W High
$2.616
52W Position info
21% above low
Off High info
53% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

CHRS sits 21% above its 52-week low of $1.02.

Summary

Coherus Oncology is issuing a special dividend of contingent value rights tied to future monetization of its legacy biosimilar assets, and has begun a sale process for those assets. This follows the company's Q2 report showing $105.3M in cash and a narrower loss, and a recent $55M debt refinancing. The CVR structure lets shareholders capture upside from asset sales without immediate cash outlay, while the sale process could bring in non-dilutive capital. The move signals a strategic pivot toward LOQTORZI and pipeline development. Watch for announcements of interested buyers or deal terms for the biosimilar portfolio.

At the time of this announcement, CHRS was trading at $1.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $177.7M. The 52-week trading range was $1.02 to $2.62. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CHRS - Latest Insights

CHRS
Nov 09, 2026, 4:59 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.8008
Real-time Price: $0.3729 info
Change: -$0.4279 (-53%) info
Market Cap: $56.862M info
CHRS
Nov 09, 2026, 4:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7976
Real-time Price: $0.3729 info
Change: -$0.4247 (-53%) info
Market Cap: $56.862M info
CHRS
Nov 09, 2026, 4:07 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.770
Real-time Price: $0.3729 info
Change: -$0.3971 (-52%) info
Market Cap: $56.862M info
CHRS
Oct 29, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $0.3729 info
Change: -$0.6771 (-64%) info
Market Cap: $56.862M info
CHRS
Sep 23, 2026, 1:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.25
Real-time Price: $0.3729 info
Change: -$0.8721 (-70%) info
Market Cap: $56.862M info